Hopp til hovedinnhold

Karcinoid syndrom

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Liu EH, Solorzano CC, Katznelson L, Vinik AI, Wong R, Randolph G; AACE Endocrine Surgery Scientific Committee AACE Endocrine Surgery Scientific Committee – Neuroendocrine Carcinoid Subgroup. Aace/Ace disease state clinical review: diagnosis and management of midgut carcinoids.. Endocr Pract. 2015; May;21(5):534-45: 534-45. pmid:25962092 PubMed  
  2. Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol. 2020 Aug 15;12(8):791-807. PMID: 32879660 PubMed  
  3. Gade AK, Olariu E, Douthit NT. Carcinoid Syndrome: A Review. Cureus. 2020 Mar 5;12(3):e7186. PMID: 32257725 PubMed  
  4. Loughrey PB, Zhang D, Heaney AP. New Treatments for the Carcinoid Syndrome. Endocrinol Metab Clin North Am. 2018 Sep;47(3):557-576. PMID: 30098716 PubMed  
  5. Riechelmann RP, Pereira AA, Rego JF, Costa FP. Refractory carcinoid syndrome: a review of treatment options.Ther Adv Med Oncol. 2017 Feb;9(2):127-137. PMID: 28203303 PubMed  
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Unn Ljøstad, spesialist i nevrologi, professor PhD